MRI study sharpens local staging picture for canine bone sarcomas

A prospective study in the Journal of Small Animal Practice examined MRI findings in 20 dogs with confirmed primary appendicular bone sarcoma and found that MRI, especially T2 short-tau inversion recovery (STIR) sequences, showed greater intramedullary tumor extension than CT and other MRI sequences. The dogs were recruited at a single referral center in France between June 2023 and October 2024, and all underwent MRI after contrast-enhanced CT for staging. Most cases were osteosarcoma (15/20), with four primary bone sarcomas of uncertain origin and one hemangiosarcoma. Across the cohort, STIR sequences consistently highlighted tumor extent, and MRI also raised suspicion for a skip metastasis in one dog that CT did not identify. (pubmed.ncbi.nlm.nih.gov)

Why it matters: For veterinary teams managing appendicular bone tumors, the study adds prospective evidence that MRI may improve local staging beyond what CT alone shows, particularly when defining intramedullary spread before surgery or limb-sparing discussions. That fits with broader canine osteosarcoma guidance, which says advanced imaging can help with precise tumor localization and local tissue assessment, even though it isn't required for every case. In practice, the findings may be most relevant for referral centers, surgical planning, and cases where margins or implant decisions depend on the true longitudinal extent of disease. (pubmed.ncbi.nlm.nih.gov)

What to watch: Whether larger, multicenter studies confirm that adding MRI, particularly STIR sequences, changes surgical decision-making, margin planning, or outcomes in dogs with appendicular bone sarcoma. (pubmed.ncbi.nlm.nih.gov)